Sale!
Replica of Osimertinib Targeted Therapy for EGFR-Mutated NSCLC
Replica of Osimertinib Targeted Therapy for EGFR-Mutated NSCLC - Image 2

Replica of Osimertinib Targeted Therapy for EGFR-Mutated NSCLC

Original price was: $677.00.Current price is: $518.00.

Lung cancer drug, third-generation, irreversible EGFR-TKI, treats EGFR mutated NSCLC, EGFR Ex19Del

SKU: SKU67ESJBLJJ Category:
Contact via Email Contact via WhatsApp
Guaranteed Safe Checkout

Lung cancer drug, third-generation, irreversible EGFR-TKI, treats EGFR mutated NSCLC, EGFR Ex19Del

Reviews

There are no reviews yet.

Be the first to review “Replica of Osimertinib Targeted Therapy for EGFR-Mutated NSCLC”

Your email address will not be published. Required fields are marked *

Related products

Scroll to Top